Related references
Note: Only part of the references are listed.Clarithromycin Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Airway Cells
Tsuyoshi Tanabe et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis
Andrea Mencarelli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
R. Vos et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Azithromycin for Prevention of Exacerbations of COPD
Richard K. Albert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study
Mathieu Coeman et al.
Therapeutic Advances in Respiratory Disease (2011)
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Soichiro Kanoh et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Azithromycin induces anti-viral responses in bronchial epithelial cells
V. Gielen et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa A Randomized Controlled Trial
Lisa Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
A trial of clarithromycin for the treatment of suboptimally controlled asthma
E. Rand Sutherland et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome
Raksha Jain et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia
Miyuki Morozumi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2010)
Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial
Nadia Yousaf et al.
THORAX (2010)
British Thoracic Society guideline for non-CF bronchiectasis
M. C. Pasteur et al.
THORAX (2010)
Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis
Magali Meyer et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Azithromycin and Clarithromycin Inhibit Lipopolysaccharide-Induced Murine Pulmonary Neutrophilia Mainly through Effects on Macrophage-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-1β
Martina Bosnar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Aerosol Antibiotics in Cystic Fibrosis
David E. Geller
RESPIRATORY CARE (2009)
Effects of prolonged use of azithromycin in patients with cystic fibrosis: A meta-analysis
D. F. Florescu et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Clarithromycin targets neutrophilic airway inflammation in refractory asthma
Jodie L. Simpson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations
Terence A. R. Seemungal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease
Sandra Hodge et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
EM703, a new derivative of erythromycin, inhibits transforming growth factor-beta signaling in human lung fibroblasts
ChangHe Yu et al.
EXPERIMENTAL LUNG RESEARCH (2008)
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study
Robert C. Strunk et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Azithromycin alters macrophage phenotype
Brian S. Murphy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts
Hideyuki Ikeda et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2008)
Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P-aeruginosa lung infection in Cftr-/- mice
Nadine Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: A preliminary report
Giorgio L. Piacentini et al.
ALLERGY AND ASTHMA PROCEEDINGS (2007)
Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF
Ruzica Pujic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome
Geert M. Verleden et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma
David L. Hahn et al.
PLOS CLINICAL TRIALS (2006)
The effect of telithromycin in acute exacerbations of asthma
SL Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis
SJ Phaff et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis
E Yalçin et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Effect of clarithromycin on rhinovirus-16 infection in A549 cells
YJ Jang et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Meta-analysis of bacterial resistance to macrolides
MT Halpern et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Interleukin-1β causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung
U Lappalainen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD
D Banerjee et al.
RESPIRATORY MEDICINE (2005)
Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma
E Kostadima et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells:: Possible role in the signaling pathway that regulates nuclear factor-κB activation
M Desaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4
S Bozinovski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase
PJ Barnes et al.
LANCET (2004)
Oral erythromycin and the risk of sudden death from cardiac causes
WA Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Macrolides and ketolides: azithromycin, clarithromycin, telithromycin
JM Zuckerman
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2004)
Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection
WC Tsai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Regulatory effects of macrolides on bacterial virulence: Potential role as quorum-sensing inhibitors
K Tateda et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Effects of six-week clarithromycin therapy in corticosteroid-dependent asthma: A randomized, double-blind, placebo-controlled pilot study
MH Gotfried et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2004)
Azithromycin in, patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa -: A randomized controlled trial
L Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells
T Shimizu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis
J Kadota et al.
RESPIRATORY MEDICINE (2003)
Maintenance azithromycin therapy for bronchiolitis obliterans syndrome - Results of a pilot study
SG Gerhardt et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
International guidelines for the treatment of community-acquired pneumonia in adults - The role of Macrolides
TM File et al.
DRUGS (2003)
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids
RH Green et al.
THORAX (2002)
Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial
A Equi et al.
LANCET (2002)
Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects
O Culic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma -: Effect of clarithromycin
M Kraft et al.
CHEST (2002)
Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-κB transcription factors
T Kikuchi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma
A Ekici et al.
JOURNAL OF ASTHMA (2002)
Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study
JD Spahn et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2001)
Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease
DE Griffith et al.
CLINICAL INFECTIOUS DISEASES (2001)
Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma
KW Garey et al.
CHEST (2000)
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis
AT Hill et al.
AMERICAN JOURNAL OF MEDICINE (2000)
Share Paper
